|
 For more information please contact:
Alison Zeigle
212.554.5469
alison@cameronassoc.com |
QuickLinks:
Press Releases »
Client Website »
Stock Quote »
Client Calendar » |
|
October 1, 2010:
ENCORIUM GROUP, INC. EXTENDS EXPIRATION OF ITS PENDING RIGHTS OFFERING
- download word.doc (40 Kb) »
|
September 13, 2010:
ENCORIUM GROUP, INC. PROVIDES UPDATE ON ITS PREVIOUSLY ANNOUNCED RIGHTS OFFERING
- download word.doc (40 Kb) »
|
August 23, 2010:
ENCORIUM GROUP, INC. ANNOUCES TERMS OF PROPOSED RIGHTS OFFERING
- download word.doc (40 Kb) »
|
August 17, 2010:
Encorium Reports Second Quarter 2010 Financial Results
- download word.doc (40 Kb) »
|
May 10, 2010:
Encorium Group, Inc. Announces New Business Contract Wins of $6.8 Million, Including Two Pivotal Phase III Studies for a Major Asian Technology Company
- download word.doc (40 Kb) »
|
January 14, 2010:
Encorium Re-Appoints Dr. Kai Lindevall as Chief Executive Officer and Appoints Current Director, Shahab Fatheazam, Chairman of the Board;
- download word.doc (40 Kb) »
|
November 16, 2009:
Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting
- download word.doc (40 Kb) »
|
October 19, 2009:
Encorium Group, Inc. Completes $1.6 Million Private Placement of Common Stock and Executes Warrant Exchange Agreement; Ends Discussions to Sell Encorium OY
- download word.doc (40 Kb) »
|
September 9, 2009:
Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial Win
- download word.doc (40 Kb) »
|
August 31, 2009:
Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity
- download word.doc (40 Kb) »
|
August 27, 2009:
Encorium Announces Receipt of Letters from NASDAQ Regarding its Second Quarter 2009 Form 10-Q Filing
- download word.doc (40 Kb) »
|
August 24, 2009:
Encorium Reports Second Quarter 2009 Financial Results
- download word.doc (40 Kb) »
|
July 17, 2009:
Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes
- download word.doc (40 Kb) »
|
July 1, 2009:
Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business
- download word.doc (40 Kb) »
|
June 18, 2009:
Encorium Group Amends LOI with Respect to the Sale of its U.S. Business; Provides Update to LOI for Sale of its
European Business
- download word.doc (40 Kb) »
|
May 19, 2009:
Encorium Reports First Quarter 2009 Financial Results
- download word.doc (40 Kb) »
|
May 18, 2009:
Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
- download word.doc (40 Kb) »
|
May 11, 2009:
Encorium Group Enters into Non-Binding Letters of Intent
- download word.doc (40 Kb) »
|
April 29, 2009:
Encorium Named as Finalist for the Second Annual Vaccine Industry Excellence Award
- download word.doc (40 Kb) »
|
April 27, 2009:
Encorium Reports Fourth Quarter and Full Year 2008 Financial Results
- download word.doc (40 Kb) »
|
April 27, 2009:
Encorium Group Signs Approximately $2.0 Million of New Business Contracts
- download word.doc (40 Kb) »
|
April 24, 2009:
Encorium Announces Receipt of Letter from NASDAQ Regarding its 2008 Form 10-K Filing
- download word.doc (40 Kb) »
|
March 31, 2009:
Encorium Group Postpones Filing of 10-K as it Evaluates Goodwill Impairment Charge
- download word.doc (40 Kb) »
|
January 27, 2009:
Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
- download word.doc (40 Kb) »
|
November 28, 2008:
Encorium Announces Receipt of Letter from NASDAQ Regarding its Third Quarter 2008 Form 10-Q Filing
- download word.doc (40 Kb) »
|
November 26, 2008:
Encorium Reports Third Quarter 2008 Financial Results
- download word.doc (40 Kb) »
|
November 18, 2008:
Encorium Group Signs $6.5 Million of New Business Contracts Mainly Consisting of Oncology Clinical Trials with a U.S. Biopharmaceutical Company
- download word.doc (40 Kb) »
|
November 11, 2008:
Encorium Appoints Shahab Fatheazam to its Board of Directors
- download word.doc (40 Kb) »
|
October 6, 2008:
Encorium Announces Stock Buyback; Provides Business and Financial Update
- download word.doc (40 Kb) »
|
October 1, 2008:
Encorium Announces Receipt of NASDAQ Letter Regarding Compliance with NASDAQ's Independent Director and Audit Committee Requirements
- download word.doc (40 Kb) »
|
September 22, 2008:
Encorium Announces the Initiation of a Strategic Partnership with Prologue Research after the Postponement of Negotiations Regarding its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investigated
- download word.doc (40 Kb) »
|
September 22, 2008:
Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials.
- download word.doc (40 Kb) »
|
September 10, 2008:
Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
- download word.doc (40 Kb) »
|
